Biases in the identification of risk factor thresholds and J-curves

被引:30
作者
Marschner, Ian C.
Simes, R. John
Keech, Anthony
机构
[1] Asia Biometr Ctr, Pfizer Australia, W Ryde, NSW 2114, Australia
[2] Asia Biometr Ctr, Pfizer Australia, Sydney, NSW, Australia
[3] Univ Sydney, Nat Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia
关键词
bias (epidemiology); cardiovascular diseases; confounding factors (epidemiology); effect modifiers (epidemiology); incidence; primary prevention; risk factors;
D O I
10.1093/aje/kwm145
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
For some diseases, there has been controversy about whether key risk factors are related linearly to the occurrence of disease events. This issue has important implications for strategies to modify risk factors, since nonlinear threshold or J-curve associations imply that risk factor modification is not beneficial beyond a certain level. This paper considers whether nonlinear risk factor associations can arise spuriously from selection mechanisms common in prospective cohort studies. Using theory, simulation, and cohort data, the authors show that selecting individuals based on their prior disease status leads to the primary risk factor being negatively confounded with other residual risk factors. If this confounding combines with effect modification between the primary and residual risk factors, as exists in cardiovascular disease, then the aggregate effect is nonlinear distortion of the risk factor relation. Such distortion can produce an apparent threshold or J-curve relation, even if the true underlying relation is linear. The authors conclude that nonlinear risk factor associations observed in primary or secondary prevention cohorts should be interpreted with caution because they may be consistent with an underlying linear lower-is-better relation. Randomized studies provide an important complement to prospective cohort studies when choosing between intensive and moderate risk factor modification strategies in high-risk populations.
引用
收藏
页码:824 / 831
页数:8
相关论文
共 26 条
[1]
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[2]
The IDEAL cholesterol - Lower is better [J].
Cannon, CP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2492-2494
[3]
Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[4]
Carroll RJ., 1995, MEASUREMENT ERROR NO
[5]
Clarke R, 1999, AM J EPIDEMIOL, V150, P341
[6]
RELATION OF LOW DIASTOLIC BLOOD-PRESSURE TO CORONARY HEART-DISEASE DEATH IN PRESENCE OF MYOCARDIAL-INFARCTION - THE FRAMINGHAM-STUDY [J].
DAGOSTINO, RB ;
BELANGER, AJ ;
KANNEL, WB ;
CRUICKSHANK, JM .
BRITISH MEDICAL JOURNAL, 1991, 303 (6799) :385-389
[7]
THE J-CURVE PHENOMENON IN STROKE RECURRENCE [J].
IRIE, K ;
YAMAGUCHI, T ;
MINEMATSU, K ;
OMAE, T .
STROKE, 1993, 24 (12) :1844-1849
[8]
Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7
[9]
Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].
LaRosa, JC ;
Grundy, SM ;
Waters, DD ;
Shear, C ;
Barter, P ;
Fruchart, J ;
Gotto, AM ;
Greten, H ;
Kastelein, JJP ;
Shepherd, J ;
Wenger, NK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435
[10]
BY HOW MUCH AND HOW QUICKLY DOES REDUCTION IN SERUM-CHOLESTEROL CONCENTRATION LOWER RISK OF ISCHEMIC-HEART-DISEASE [J].
LAW, MR ;
WALD, NJ ;
THOMPSON, SG .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6925) :367-373